We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

IMXI:NASDAQInternational Money Express, Inc. Analysis

Data as of 2026-06-14 - not real-time

$14.99

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

IMXI is trading near its recent support level with the 20‑day SMA just above the 50‑day SMA, indicating a neutral technical stance. The RSI sits in the low‑mid 40s, suggesting limited upside momentum, while the MACD line is marginally below its signal, giving a bearish tilt. Volatility over the past month is moderate and beta is notably low, pointing to limited price swings relative to the market. Valuation metrics show the price‑earnings multiple well below the industry average and a forward PE that is substantially lower, implying the stock may be undervalued on a price basis. However, the company’s fundamentals are mixed: revenue is contracting, operating margins are negative, and cash flow from operations is negative, while leverage is high with debt outpacing equity. There is no dividend, so income‑focused investors have little appeal. Recent news that a New York mayor is attempting to block a Western Union partnership adds regulatory uncertainty and could pressure the share price in the short run. Despite stable trading volume and a market cap that provides reasonable liquidity, the combination of earnings weakness and geopolitical exposure creates a cautious outlook. Investors should weigh the undervalued price against the operational challenges and regulatory headwinds before acting.
Overall, the stock sits at a crossroads where technical indicators are neutral, valuation appears attractive, but fundamental and regulatory risks temper enthusiasm. A short‑term hold or modest sell may be prudent until the regulatory issue resolves, while a longer‑term view could be more optimistic if the company can improve cash generation and stabilize revenues.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Technical indicators are neutral with slight bearish bias
  • Regulatory uncertainty from the Western Union deal news
  • Support level proximity and modest volatility

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Undervalued valuation relative to industry peers
  • Potential earnings improvement from forward EPS expectations
  • Continued operating cash flow challenges

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Price appears attractive given low forward PE
  • Opportunity for turnaround if cash flow becomes positive
  • Diversified geographic footprint could drive growth once regulatory hurdles clear

Key Metrics & Analysis

Financial Health

Revenue Growth-14.90%
Profit Margin4.31%
P/E Ratio17.6
ROE16.83%
ROA7.63%
Debt/Equity161.21
P/B Ratio2.8
Op. Cash Flow$-41759000
Free Cash Flow$-62735248
Industry P/E36.8

Technical Analysis

TrendNeutral
RSI41.8
Support$14.63
Resistance$15.52
MA 20$15.11
MA 50$15.54
MA 200$15.27
MACDBearish
VolumeStable
Fear & Greed Index89.86

Valuation

Target Price$16.00
Upside/Downside6.74%
GradeUndervalued
TypeValue

Risk Assessment

Beta0.15
Volatility17.40%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.